Technological development in the field of circulating biomarkers has allowed the identification of circulating tumor cells in the peripheral blood of patients with glioblastoma. This opens a new avenue of research with implications for the understanding and clinical managing of this fatal disease.
©2014 American Association for Cancer Research.